Teleflex Incorporated issued $500,000,000 in 5.875% senior notes due January 2032, which pay interest semi-annually on January 15 and July 15. The notes are general unsecured senior obligations of the company and its domestic subsidiaries. Teleflex Incorporated is a medical technology company that develops and manufactures products for various medical specialties.

Teleflex Incorporated's Board of Directors approved a special restricted stock unit award of $600,000 grant date fair value to Stuart A. Randle to recognize his contributions as Interim President and Chief Executive Officer. The award, granted on June 8, 2026, vests on either June 8, 2027, or the date of the Company's 2027 annual meeting of stockholders. Teleflex Incorporated is a medical technology company that manufactures and distributes medical devices and accessories.